Crowe D T, Chiu H, Fong S, Weissman I L
Department of Pathology, Stanford University School of Medicine, California 94305.
J Biol Chem. 1994 May 20;269(20):14411-8.
Integrins are cell-surface heterodimeric receptors with adhesive and transmembrane signaling properties. Their cytoplasmic domains can affect receptor avidity, cytoskeletal association, and post-receptor occupancy events. The alpha 4 beta 7 integrin mediates cell adhesion to Peyer's patch high walled endothelial venules (HEV), VCAM, and CS-1/fibronectin. To determine the role of the beta 7 cytoplasmic domain in these interactions, wild-type and truncated beta 7 subunits were stably expressed in the alpha 4+/beta 1-/beta 7- B cell lymphoma 38C13. The cell line delta 727 lacks the entire beta 7 cytoplasmic domain, delta 753 lacks the 34 C-terminal residues, and LXSN is vector-transfected 38C13. Cells expressing wild-type beta 7 bound Peyer's patch HEV, fibronectin, and immobilized VCAM constitutively and did not require prior activation with phorbol esters. Interestingly, delta 753 displayed no ligand binding activity, while delta 727 was constitutively active for all ligands and displayed greater avidity for fibronectin and Peyer's patch HEV than the wild-type beta 7. beta 7, delta 753, delta 727, and LXSN were also tested for the ability to bind soluble VCAM in the presence of various divalent cations. In the presence of Ca2+, but not Mg2+, delta 727 constitutively bound soluble VCAM, whereas beta 7, delta 753, and LXSN did not. beta 7 and delta 753 could bind soluble VCAM if first activated with Mn2+. The results suggest that: (i) alpha 4 beta 7 can be expressed in a constitutively active state, (ii) the beta 7 cytoplasmic domain regulates the avidity of alpha 4 beta 7, and (iii) 38C13 cell lines expressing wild-type and truncated beta 7 subunits define three stable activation states of alpha 4 beta 7: inactive (delta 753), partially active (beta 7), and fully active (delta 727) receptors.
整合素是具有黏附及跨膜信号传导特性的细胞表面异源二聚体受体。它们的胞质结构域可影响受体亲和力、细胞骨架结合以及受体占据后的事件。α4β7整合素介导细胞与派尔集合淋巴结高壁内皮小静脉(HEV)、血管细胞黏附分子(VCAM)以及CS-1/纤连蛋白的黏附。为确定β7胞质结构域在这些相互作用中的作用,野生型和截短的β7亚基在α4+/β1-/β7- B细胞淋巴瘤38C13中稳定表达。细胞系δ727缺失整个β7胞质结构域,δ753缺失34个C末端残基,而LXSN是用载体转染的38C13。表达野生型β7的细胞组成性地结合派尔集合淋巴结HEV、纤连蛋白和固定化的VCAM,且不需要预先用佛波酯激活。有趣的是,δ753没有显示出配体结合活性,而δ727对所有配体均组成性激活,并且对纤连蛋白和派尔集合淋巴结HEV的亲和力高于野生型β7。还测试了β7、δ753、δ727和LXSN在各种二价阳离子存在下结合可溶性VCAM的能力。在Ca2+存在但Mg2+不存在的情况下,δ727组成性地结合可溶性VCAM,而β7、δ753和LXSN则不能。如果先用Mn2+激活,β7和δ753可以结合可溶性VCAM。结果表明:(i)α4β7可以以组成性激活状态表达;(ii)β7胞质结构域调节α4β7的亲和力;(iii)表达野生型和截短β7亚基的38C13细胞系定义了α4β7的三种稳定激活状态:无活性(δ753)、部分活性(β7)和完全活性(δ727)受体。